TRGel develops glucose-based biopolymers that can be used instead of calcium alginate for encapsulation.
TRGel develops glucose-based biopolymers that can be used instead of calcium alginate for encapsulation. The company was founded in 2010 and is based in Irvine, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 15, 2021 | Grant | $256K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |